Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 7973-1 (MIR7973-1, also known as hsa-mir-7973-1) is a small, non-coding RNA molecule (microRNA) expressed in human granulosa cells and encoded within an intron of the aromatase gene (CYP19A1)[1]. It acts post-transcriptionally to regulate gene expression by binding target messenger RNAs and promoting their degradation or inhibiting their translation. Experimental evidence identified ADAM19, PXDN, and FMNL3 as direct gene targets of hsa-miR-7973-1, indicating roles in extracellular matrix modulation and cell–cell interactions, which may influence granulosa cell function and ovarian follicle development[1]. However, MIR7973-1 is not currently considered a classical therapeutic target, nor are there drugs or approved therapies that directly interact with it[1][3][7]. Its clinical disease relevance remains to be clearly defined.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 7973-1 (MIR7973-1).